![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | ![]() Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | ![]() XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
| |||
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 2005 | Founding Date 2016 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Watertown, US HQ Cambridge, US | Locations Cambridge, US HQ Cambridge, US | Locations Austin, US HQ | Locations Redwood City, US HQ Boston, US | Locations Boston, US HQ |
Employees | Employees 207 | Employees 1123% decrease | Employees 8510% decrease | Employees 1438% increase | Employees 891% increase |
Valuation ($) | Valuation ($) 3.1 b | Valuation ($) 452 m | Valuation ($) 234.4 m | Valuation ($) 116.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $39.2m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($311.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) | Net income ($45.5m) (FY, 2025) | Net income ($116.8m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 197m | Total funding raised $ 50m | Total funding raised N/A | Total funding raised $ 145.6m | Total funding raised $ 50m |

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
View company
Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
View company